You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 10,646,572


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,646,572 protect, and when does it expire?

Patent 10,646,572 protects CAMCEVI KIT and is included in one NDA.

This patent has twenty patent family members in fifteen countries.

Summary for Patent: 10,646,572
Title:Pharmaceutical compositions with enhanced stability
Abstract: The present invention provides for a stabilized biodegradable polymeric composition useful as a controlled release delivery system for peptide agents. The compositions of the present invention comprise a) a beneficial salt of a luteinizing hormone releasing hormone (LHRH) analogue formed with a strong acid that minimizes or prevents the interaction/reaction between the LHRH and the polymer in an organic solution; b) a biodegradable polymer; c) a pharmaceutically acceptable organic solvent; and d) optionally one or more excipients. The present invention also relates to a method of manufacturing and a method of use thereof.
Inventor(s): Li; Yuhua (Landenberg, PA), Chien; Benjamin (Woodside, CA)
Assignee: Foresee Pharmaceuticals Co., Ltd. (Nankang Dist., Taipei, TW)
Application Number:16/376,028
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,646,572

Introduction to U.S. Patents

When analyzing a U.S. patent, it is crucial to understand the various sections and their significance. A U.S. patent, such as United States Patent 10,646,572, is a complex document that includes several key components: the specification, drawings, and claims.

Document Structure

  • Document Number and Type: The prefix "US" indicates it is a U.S. patent, and the code "B2" suggests it has a previously published application[1].
  • Application Number and Date: These details are critical for tracing the patent's history and priority dates[1].
  • Patent Date: The date when the patent was granted, marking the beginning of the patent term[1].
  • IPC and National Classification: These codes categorize the invention within the international and national patent classification systems, respectively[1].

Specification

The specification is a written description of the invention, including:

  • Related Prior Art: A discussion of previously issued patents and other publications relevant to the invention[1].
  • Description of Drawings: An explanation of the technical details illustrated in the drawings section[1].
  • Technical Problem and Solution: How the invention addresses a specific technical issue[1].
  • Preferred Embodiment: A detailed description of the invention's preferred form[1].

Drawings

The drawings section contains black and white illustrations that technically detail the invention. These drawings are essential for understanding the invention's structure and operation[1].

Claims

Definition and Purpose

Claims are paragraphs at the end of the specification that define the scope of protection for the patent. They are preceded by phrases like “I claim” or “What is claimed” and are numbered. Claims legally define the boundaries of the invention, similar to how a property deed defines land boundaries[1].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims. They are often used to measure patent scope, with longer independent claims generally indicating broader scope[3].
  • Dependent Claims: These claims build upon independent claims and further narrow the scope of the invention.

Importance of Claims

Claims are critical because they determine what is protected by the patent. Broader claims may cover more variations of the invention but are also more likely to face challenges during the examination process. Narrower claims, while more specific, may have a higher probability of being granted but offer less protection[3].

Patent Scope and Quality

The scope of a patent is a key aspect of patent quality debates. Metrics such as independent claim length and count can help measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process, indicating better patent quality[3].

Obviousness-Type Double Patenting

Obviousness-type double patenting (ODP) is a doctrine that prevents patentees from extending the life of a first patent by obtaining a second patent on a patentably indistinct invention. Recent Federal Circuit decisions have clarified that a first-filed, first-issued, later-expiring patent claim cannot be invalidated for ODP by a later-filed, later-issued, earlier-expiring reference patent claim with a common priority date[2].

Patent Eligibility and AI Inventions

The 2024 USPTO guidance update on AI patents emphasizes the integration of judicial exceptions into practical applications. For AI-related inventions, the focus is on whether the claimed invention offers a concrete technological improvement. Claims must demonstrate meaningful limits on abstract ideas, transforming them into patent-eligible subject matter. Examples provided by the USPTO illustrate how specific applications of AI technologies can meet eligibility criteria[4].

Practical Applications and Real-World Benefits

To be patent-eligible, claims must show how the abstract idea is applied in a way that provides concrete benefits or solves specific problems. For instance, a claim involving an artificial neural network designed to identify anomalies in a specific application, like a speech recognition system, can meet eligibility criteria by demonstrating an improvement in computer technology[4].

Patent Prosecution and Examination

The patent prosecution process can be lengthy, often taking two to five years. If the claimed invention is not patentable as submitted, arguments and amended claims must be presented. If the patent examiner does not accept these, an appeal to an appeal board or the U.S. court system may be necessary. The costs associated with drafting, filing, and prosecuting a patent can be significant, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and even higher for international patents[5].

Key Takeaways for United States Patent 10,646,572

  • Detailed Specification: The patent must include a thorough description of the invention, prior art, and technical details.
  • Claims Analysis: The claims define the legal boundaries of the invention and must be carefully crafted to ensure they are patentable and not overly broad.
  • Patent Scope: Metrics like independent claim length and count can help assess the patent's scope and quality.
  • Obviousness-Type Double Patenting: Ensure that the patent does not fall under ODP by verifying the priority dates and expiration dates of related patents.
  • AI and Patent Eligibility: For AI-related inventions, focus on integrating judicial exceptions into practical applications to ensure patent eligibility.
  • Practical Applications: Claims must demonstrate real-world benefits and solve specific problems to be considered patent-eligible.

FAQs

Q: What is the purpose of the specification in a U.S. patent? A: The specification provides a written description of the invention, including related prior art, a description of the drawings, the technical problem solved, and the preferred embodiment of the invention.

Q: How do claims define the scope of a patent? A: Claims define the legal boundaries of the invention, specifying what is protected by the patent. They must be clear and specific to avoid challenges during the examination process.

Q: What is obviousness-type double patenting (ODP)? A: ODP is a doctrine that prevents patentees from obtaining a second patent on a patentably indistinct invention to extend the life of a first patent.

Q: How does the 2024 USPTO guidance update affect AI-related patent claims? A: The update clarifies that AI-related claims must integrate judicial exceptions into practical applications to be patent-eligible, focusing on concrete technological improvements.

Q: What are the typical costs associated with patenting a U.S. invention? A: The costs can range from $8,000 to $20,000 for drafting and filing a U.S. non-provisional patent application, with additional costs for patent prosecution and maintenance.

Sources

  1. Guides.library.queensu.ca: How to Read a U.S. Patent - Patents and Designs - Research Guides.
  2. Whitecase.com: Federal Circuit Limits the Application of Obviousness-Type Double Patenting for Patents in the Same Family.
  3. SSRN.com: Patent Claims and Patent Scope.
  4. Mintz.com: Understanding the 2024 USPTO Guidance Update on AI Patent.
  5. KU Office of Research: Intellectual Property Protection.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,646,572

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Accord CAMCEVI KIT leuprolide mesylate EMULSION;SUBCUTANEOUS 211488-001 May 25, 2021 RX Yes Yes 10,646,572 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,646,572

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2007207618 ⤷  Subscribe
Brazil PI0706558 ⤷  Subscribe
Canada 2637569 ⤷  Subscribe
China 101400363 ⤷  Subscribe
Denmark 1984009 ⤷  Subscribe
European Patent Office 1984009 ⤷  Subscribe
Spain 2397712 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.